Drug Discovery Market
Drug Discovery Market Size And Forecast
Drug Discovery Market was valued at USD 39.02 Billion in 2018 and is projected to reach USD 73.17 Billion by 2026, growing at a CAGR of 8.2 % from 2019 to 2026.
Global Drug Discovery Market Outlook
The increasing prevalence of a wide range of diseases such as cardiovascular and CNS-related disorders among all the age groups, rising healthcare expenditure, as well as upsurge in the usage of advanced technologies, such as high throughput, bioinformatics, and combinatorial chemistry are the factors boosting the market growth. Moreover, a rise in demand for specialty medicines is expected to fuel market growth. On the other hand, the high costs associated with the drug discovery & development process and stringent regulatory framework might act as restraints and hinder the overall growth.
Global Drug Discovery Market Competitive Landscape
The Global Drug Discovery Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Pfizer Inc., GlaxoSmithKline PLC, Merck & Co. Inc., Agilent Technologies Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Bayer AG, Abbott Laboratories Inc., AstraZeneca PLC, Shimadzu Corp.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.